Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 12/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NQO1 | P15559 | 1/20 | 0.39 |
| ▸ | DHFR | P00374 | 1/20 | 0.38 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20442498 | 0.93 | MEN1 (0.46) | MEN1KMT2AHPGDSMN1; SMN2NQO1 | |
| SCHEMBL18284504 | 0.86 | MEN1 (0.39) | ACACBMEN1KMT2ADHFRTNK2 | |
| SCHEMBL21400656 | 0.86 | APP (0.44) | ACACBMEN1KMT2AHPGD | |
| SCHEMBL21400657 | 0.83 | APP (0.44) | ACACBMEN1KMT2ADHFRTNK2 | |
| SCHEMBL1930808 | 0.83 | MEN1 (0.47) | MEN1KMT2AHPGDSMN1; SMN2 | |
| SCHEMBL1931849 | 0.82 | MEN1 (0.45) | ACACBMEN1KMT2AHPGDSMN1; SMN2 | |
| SCHEMBL673176 | 0.82 | TNK2 (0.38) | ACACBMEN1KMT2ADHFRTNK2 | |
| SCHEMBL674017 | 0.81 | ACACB (0.38) | ACACBMEN1KMT2ADHFRTNK2 | |
| SCHEMBL26842987 | 0.81 | MEN1 (0.36) | ACACBMEN1KMT2ADHFRTNK2 | |
| SCHEMBL7362854 | 0.81 | HRH3 (0.42) | ACACBMEN1KMT2ADHFRTNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110137064-A1 | METHACRYLATE-BOUND PHOTOISOMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS | MEMPILE INC. (US) | 2011-06-09 | — | — | US | disclosed |
| US-20090161516-A1 | METHACRYLATE-BOUND PHOTOISMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS AND OF ITS INTERMEDIATES | MEMPILE INC. (US) | 2009-06-25 | — | — | US | disclosed |
| EP-1888511-A1 | A METHACRYLATE-BOUND PHOTOISOMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS AND OF ITS INTERMEDIATES | Mempile Inc. (US) | 2008-02-20 | — | — | EP | disclosed |
| WO-2006117791-A1 | A METHACRYLATE-BOUND PHOTOISOMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS AND OF ITS INTERMEDIATES | MEMPILE INC. (US) | 2006-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110137064-A1 | METHACRYLATE-BOUND PHOTOISOMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS | MMAB, TET3, KDM2B | ACACB 1548/4885MEN1 457/4885KMT2A 128/4885 |
| US-20090161516-A1 | METHACRYLATE-BOUND PHOTOISMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS AND OF ITS INTERMEDIATES | MMAB, HMBS, KDM2B | ACACB 846/4885MEN1 444/4885KMT2A 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.